Market revenue in 2023 | USD 7.8 million |
Market revenue in 2030 | USD 20.8 million |
Growth rate | 15% (CAGR from 2023 to 2030) |
Largest segment | Cytokines & growth factors |
Fastest growing segment | Cytokines & Growth Factors |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Cytokines & Growth Factors, Antibodies, Immune checkpoint proteins, Virus Antigens, Enzymes, Recombinant Regulatory Protein, Hormones |
Key market players worldwide | Thermo Fisher Scientific Inc, Danaher Corp, Bio-Techne Corp, Sino Biological, Miltenyi Biotec, Proteintech Group, Prospec, New England Biolabs |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to research-grade proteins market will help companies and investors design strategic landscapes.
Cytokines & growth factors was the largest segment with a revenue share of 23.08% in 2023. Horizon Databook has segmented the Saudi Arabia research-grade proteins market based on cytokines & growth factors, antibodies, immune checkpoint proteins, virus antigens, enzymes, recombinant regulatory protein, hormones covering the revenue growth of each sub-segment from 2018 to 2030.
The growth of Saudi Arabia's research-grade proteins market can primarily be attributed to various initiatives undertaken by the government to expand the biotechnology sector in the country.
According to the news article published by Al Arabiya Network in June 2022, the Saudi Arabian Minister of Industry and Mineral Resources, as chairman of the biopharmaceutical industry committee, announced several investment opportunities, with an overall worth of USD 3. 4 billion, in vital medicine and vaccines to accomplish the Kingdom's pharmaceutical and health security objectives.
Moreover, according to the May 2023 press release, the government of Saudi Arabia introduced regulatory changes aimed at promoting investment and facilitating the growth of the domestic pharmaceutical sector.
Horizon Databook provides a detailed overview of country-level data and insights on the Saudi Arabia research-grade proteins market , including forecasts for subscribers. This country databook contains high-level insights into Saudi Arabia research-grade proteins market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account